Litcius/Paper detail

EZH2 inhibition confers PIK3CA-driven lung tumors enhanced sensitivity to PI3K inhibition

Fan Chen, Jinpeng Liu, Xiulong Song, Tanner J. DuCote, Aria L. Byrd, Chi Wang, Christine F. Brainson

2021Cancer Letters32 citationsDOIOpen Access PDF

Topics & Concepts

PI3K/AKT/mTOR pathwayCancer researchLung cancerMedicineCancerTargeted therapyLeukemiaBiologyImmunologyPathologyInternal medicineSignal transductionCell biologyEpigenetics and DNA MethylationPI3K/AKT/mTOR signaling in cancerRNA modifications and cancer
EZH2 inhibition confers PIK3CA-driven lung tumors enhanced sensitivity to PI3K inhibition | Litcius